Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05713695 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Supporting Treatment Access and Recovery Through Linkage and Support

Study acronym: STAR-LS
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Sep 2026 → Dec 2026
See other at-risk trials from University of Massachusetts, Worcester

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: details revised at 2 of 56 entries
    • Primary completion pushed from Sep 2026 to Dec 2026
    • Study completion pushed from Sep 2026 to Dec 2027
    • Eligibility criteria expanded, about 6 words
  2. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: May 2026 to Sep 2026
    • Site details revised
    v7
  3. Re-verified, no change to tracked fieldsv6
  4. Primary completion date: Jun 2025 to May 2026
    • Study completion date: Sep 2025 to Sep 2026
    v5
  5. Start date changed from estimate of May 25, 2023 to May 24, 2023v4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Feb 2023 to May 25, 2023
    • Study sites: 0 to 1
    v3
  2. Study description expanded, about 8 wordsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This 3-year Hybrid Type 1 study will randomize 208 people with co-occurring substance use and mental health disorders (COD) referred from the Worcester Hub. This study seeks to evaluate the effectiveness of MISSION, a multi-component team approach, versus linkage with a Peer Specialist on improving outcomes among individuals with CODs. We expect that individuals receiving MISSION versus linkage only will show greater improvement in treatment engagement, substance use, and mental health outcomes. This study will also concurrently conduct a process evaluation to inform sustainability and future implementation of such interventions.
Trial Details
NCT Number NCT05713695
Lead Sponsor University of Massachusetts, Worcester
Collaborators: Centers for Disease Control and Prevention, University of Massachusetts, Lowell, University of Massachusetts, Amherst
Conditions
(from sponsor)		 Mental Health Disorders, Substance Use Disorders
Related terms Behavior, Addictive, Opiate Overdose, Substance-Related Disorders
Enrollment 208 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov